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FOREWORD 
This publication, which constitutes the third series of reports by the 
(1) 
Scientific Committee for Animal Nutrition , contains the Committee's 
opinions on the safety of certain products proposed as additives in 
feedingstuffs and also "Guidelines for the assessment of certain pro-
ducts to be used as a source of proteins in animal nutrition". 
Since new uses of known products or new products with beneficial effects 
on the quality of feedingstuffs and on the health or growth of animals 
were involved, it was necessary to ensure that the proposed conditions 
for use fulfilled the requirements of Community legislation on feeding-
stuffs and carried no risks for animals and, indirectly, for human 
beings and the environment. The scientifically-based opinions expressed 
by the Committee dispelled any doubts in this connection. 
The "Guidelines", laid down by the Committee at the Commission's request, 
are designed to gather together the necessary documentation for the 
assessment of non-traditional products abtained from culturing micro-
organisms and likely to be authorized as new protein sources in animal 
nutrition. 
(1) The first and second series of reports have been published by the 
Office for Official Publications of the European Communities in 
Luxembourg, under catalogue numbers CB-28-79-277-EN-C and CD-NK-80-
002-EN-C respectively. 
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REPORT OF THE SCIENTIFIC COMMITTEE FOR ANIMAL NUTRITION 
ON THE USE OF FUMARIC AND MALIC ACIDS 
IN FEEDINGSTUFFS 
Opinion expressed 15 January 1980 
TERMS OF REFERENCE (March 1979) 
The Scientific Committee for Animal Nutrition is requested to give an 
opinion on the following questions : 
1. Do fumarie and DL-malic acids added to feedingstuffs act as preser-
vatives ? 
2. Can they have harmful effects on the animal organism ? 
3. Can they have adverse effects on the quality of animal products ? 
4. Taking into account the answers to the abovementioned questions, 
should the use of these acids as preservatives in feedinstuffs be 
continued and, if so, should the conditions of use be restricted ? 
BACKGROUND 
According to the provisions of Council Directive 70/524/EEC, of 23 Novem-
ber 1970, on additives in feedingstuffs (1), as last amended by the 
twenty-sixth Commission Directive of 18 December 1978 (2), Member States 
are authorized to make use, by way of derogation until 31 December 1979, 
of fumarie acid without specific conditions of use and malic acid for 
ensilaged feedingstuffs. 
It is planned to authorize these products as preservatives in feeding-
stuffs throughout the Community. 
(1) OJ No L 270, 14.12.1970, p. 1 
(2) OJ No L 39, 14. 2.1979, p. 11 
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OPINION OF THE COMMITTEE 
1. Fumarie and DL-malic acid are used as preservatives in certain 
feedingstuffs because of their antifungal and antibacterial proper-
ties. Their efficacy varies according to the conditions of use. 
2. Fumarie and L-malic acid are natural components of plant and animal 
organisms which are consumed daily. They participate in many bio-
chemical processes and are intermediate products of the Krebs cycle. 
D-malic acid and DL-malic acid (racemic mixture of the D- and L-
isomers) do not occur naturally. 
These acids have a very low acute chronic toxicity. Long-term oral 
administration of fumarie acid produced no ill effects in rats at a 
concentration of 1.2 % in the diet, in guinea pigs at 1.0 % and in 
dogs at 5.0 % (Landwirtschaftliche Schriftenreihe 1979). Long-term 
oral administration of DL-malic acid was without adverse effects in 
rats at concentrations of 0.05 % and 0.5 % in the diet. No adverse 
biological effects have been observed in dogs at a dietary concentra-
tion of 5 % (National Technical Information Service 1975). 
The Joint FA0/WH0 Expert Committee on Food Additives established an 
ADI of 6 mg/kg body weight for fumarie acid. The Codex Alimentarius 
Committee on Food Additives approved the use of this acid in jams and 
jellies, subject to a maximum level of 3 g/kg, and the use of DL-
malic acid in certain fruit and vegetable preserves, jams, jellies 
and some fruit juices. The establishment of an ADI for DL-malic acid 
was not considered necessary (Joint FA0/WH0 Food Standards Programme 
1979). 
3. Fumarie and DL-malic acid are normal intermediate metabolites in the 
animal organism and have no adverse effects on the quality of animal 
products. 
4. In view of the above, the Committee is of the opinion that the use of 
fumarie and DL-malic acid as preservatives in feedingstuffs does not 
constitute any risk for animal or human health and does not have any 
unfavourable effects on the quality of animal products. It appears 
unnecessary to lay down any specific conditions for this particular 
use of the two acids. 
NOTE 
Although the opinion of the Committee has not been requested on this 
issue, its attention was drawn to the interest in these products as 
growth promoters. A symposium held at Gelsenkirchen in 1978 (Landwirt­
schaftliche Schriftenreihe 1979) concluded that the addition of certain 
concentrations of fumarie acid to the ration appreciably improves the 
growth rate of piglets after weaning, and of calves. It also improves 
the feed conversion rate of fattening pigs and broiler chicken. Scipioni 
et al. (1979) are of the opinion that fumarie and malic acid do not 
affect the growth of piglets up to the age of two months. However, 
appreciable weight gain manifests itself from the third month onwards. 
Other recent studies have demonstrated that the addition of fumarie acid 
to the feeding stuffs for beef cattle resulted in a 5 % improvement in 
growth. 
REFERENCES 
Joint FAO/WHO Food Standards Programme Codex Alimentari us Commission, 
1979. Guide to the Safe Use of Food Additives, Second Series CAC/FAL 5­
1979. 
Landwirtschaftliche Schriftenreihe Boden, Pflanze, Tier (1979) J8. 
"Fumarsäure in der Tierernährung". Verlag Paul Parey, Hamburg­Berlin. 
National Technical Information Service 1975, doc. PB 262.662. 
Evaluation of the Health Aspects of Malic Acid as a Food Ingredient. 
U.S. Department of Commerce, P.O. Box 1553, Springfield, Virginia 22.151, 
Scipioni R., Zaghini G. e Biavatti Β., 1979. Rivista di Suinicoltura 5_, 
73­84 
(2) 
REPORT OF THE SCIENTIFIC COMMITTEE FOR ANIMAL NUTRITION 
ON THE USE OF HYDROCHLORIC AND SULPHURIC ACIDS 
IN FEEDINGSTUFFS 
Opinion expressed 15 January 1980 
TERMS OF REFERENCE (March 1979) 
The Scientific Committee for Animal Nutrition is requested to give an 
opinion on the following questions : 
1. Do hydrochloric and sulphuric acids, added at low levels to feeding-
stuffs, act as preservatives ? 
2. Can they have harmful effects on the animal organism ? 
3. Can they have adverse effects on the quality of animal products ? 
4. Taking into account the answers to the abovementioned questions, 
should the use of these acids in feedingstuffs be continued, and if 
so, should the conditions of use be restricted ? 
BACKGROUND 
According to the provisions of Council Directive 70/524/EEC, of 23 No-
vember 1970, on additives in feedingstuffs (1), as last amended by the 
twenty-sixth Commission Directive of 18 December 1978 (2), Member States 
are authorized to make use, by way of derogation until 31 December 1979, 
of hydrochloric and sulphuric acids for ensilaged feedingstuffs. 
Authorization to use these products as preservatives in feedingstuffs, 
without specific conditions of use, was requested by one Member State. 
(1) OJ No L 270, 14.12.1970, p. 1 
(2) OJ No L 39, 14.02.1979, p. 11 
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OPINION OF THE COMMITTEE 
1. The use of mixtures of mineral acids, particularly technical grade 
hydrochloric and sulphuric acids, for the preservation of ensilaged 
fodders goes back to the period 1930-1935. This method, which is 
known to be effective, consists of acidifying the fodders with a 
quantity of 5 - 10 % of mineral acids, diluted so as to obtain a pH 
of 3-4. 
More recently, it has been reported that the addition of 1 - 3 % 
concentrated hydrochloric or sulphuric acid (mixed with phosphoric 
acid) to liquid molassed feedingstuffs supplemented by non-protein 
nitrogen compounds enhanced the effectiveness of these compounds in 
ruminants. It is likely that this beneficial effect results from a 
better distributed daily consumption of non-protein nitrogen com-
pounds. It is known that the acidification of feedingstuffs leads to 
a less massive and more frequent feed consumption in ruminants and 
that this method of feeding favours the assimilation of non-protein 
nitrogen compounds. 
2. The use of hydrochloric and sulphuric acids under the conditions of 
use recommended for the preservation of ensilaged fodders does not 
present any danger for ruminants. The cases of acidosis and demine-
ralization observed resulted either from an excessive consumption of 
acidified fodder or from feeding which was deficient in alkaline 
salts. 
The addition of 1 - 3 % hydrochloric or sulphuric acid to liquid 
molassed feedingstuffs, supplemented by non-protein nitrogen com-
pounds, does not appear likely to produce metabolic disturbances. The 
consumption of these feedingstuffs by ruminants is limited. In addi-
tion the presence of heavy metals or other impurities in the techni-
cal grades of these acids (cf. Tables I and II) does not pose any 
problem at the levels at which these acids are used in feedingstuffs. 
According to the provisions of Council Directive 74/63/EEC of 17 De-
cember 1973 on the fixing of maximum permitted levels for undesirable 
substances and products in feedingstuffs (1), the maximum levels of 
arsenic, lead, fluorine and mercury tolerated in feedingstuffs for 
adult bovine animals are 2, 5, 50 and 0.1 mg/kg compound feeding-
stuff, respectively. 
(1) OJ No L 38, 11.02.1974, p. 31 
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Table I 
\ Average 
; so 
: Cl (free) 
: Fe 
: Pb 
: As 
: Cu 
: F : Dry residue 
levels 
hydrochloric 
of impurities in concentrated 
acid of technical 
50 ppm 
0 - 2 0 0 - 1 0 
none 
none 
none 
none 0.04 % 
quality " 
ppm : ppm : 
Table II 
Levels of impurities in sulphuric acid (66°B) 
of technical quality 
Calcination residue 
so2 Ammonium nitrogen 
Nitric nitrogen 
CI 
As 
Fe 
Organic Matter 
Sb 
Mn 
Cu 
Zn 
Se 
Pt 
Ni 
Ag 
Co 
Dry residue 
Ba 
Cd 
Cr 
Hg 
Pb 
F 
max. 0.01 % 
max. 0.0003 % 
max. 0.0002 % 
max. 0.0003 % 
max. 0.0005 % 
max. 0.00001 % 
max. 0.002 % 
max. 0.0005 % 
max. 0.0002 % 
max. 0.00002 % 
max. 0.0002 % 
max. 0.004 % 
max. 0.0015 % 
none 
max. 0.00005 % 
none 
max. 0.00015 % 
max. 0.008 % 
0.1 mg/l 
< 0.01 mg/l 
0.08 mg/l 
< 0.01 mg/l 
0.18 mg/l 
< 1 mg/l 
1 I — 
3. The addition of hydrochloric or sulphuric acid to ensilaged fodders 
or liquid molassed feedingstuffs containing non-protein nitrogen 
compounds is without effect on the quality of the animal products. 
4. The Committee is of the opinion that the use of hydrochloric and 
sulphuric acids is acceptable for the preservation of ensilaged 
fodders and also for improving the effectiveness of non-protein 
nitrogen compounds added to liquid molassed feedingstuffs intended 
for ruminants. The addition of these acids to other types of fee-
dingstuffs is only acceptable if supported by the relevant documen-
tary evidence. 
REFERENCES 
Grosz, 1974. Gärfutter, Ed. Eugen Ulmer, Stuttgart. 
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REPORT OF THE SCIENTIFIC COMMITTEE FOR ANIMAL NUTRITION 
ON THE USE OF POLYETHYLENE GLYCOL 6000 AND OF 
A POLYOXYPROPYLENE-POLYOXYETHYLENE POLYMER 
IN FEEDINGSTUFFS 
Opinion delivered on 15 January 1980 
TERMS OF REFERENCE (March 1979) 
The Scientific Committee for Animal Nutrition is requested to give its 
opinion on the following questions : 
Could the use of polyethylene glycol 6000 and of a polymer of poly-
oxypropylene-polyoxyethylene (M.W. 6800 - 9000) for coating vitamins 
intended for incorporation into feedingstuffs under the conditions 
proposed (cf. Background) 
- be harmful for productive livestock and/or pets ? 
- result in undesirable effects on the quality of animal products ? 
BACKGROUND 
The autori zation of the use in the Community of the products concerned 
as additives in feedingstuffs (group of emulsifiers, stabilizers, 
thickeners and gelling agents) was requested by a Member State. The 
proposed conditions of use are the following : 
- Feedingstuffs intended for all animal species 
- Maximum content : 
polyethylene glycol 6000 : 300 mg/kg of complete feedingstuffs 
polyoxypropylene-polyoxyethylene polymer (M.W. 6800 - 9000) : 50 mg/kg 
complete feedingstuffs. 
OPINION OF THE COMMITTEE 
1. Polyethylene glycols of high molecular weight (4000 - 6000) are used 
in pharmacy in the preparation of ointments, suppositories and 
tablets and they are also used in the preparation of cosmetics. They 
are water-soluble substances which act essentially as dispersants or 
binding agents. 
They are described in many pharmacopoeias. 
Polyoxypropylene-polyoxyethylene polymers are non-ionic surfactants 
used in pharmaceutical preparations and cosmetics either as emulsi-
fiers or to facilitate gastro-intestinal absorption of certain active 
substances. 
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Polyoxypropylene-polyoxyethylene polymer (M.W. 6800 - 9000) as an 
emulsifying agent, in combination with polyethylene glycol 6000 as a 
dispersant, has been found suitable for the preparation of premixes 
of liposoluble vitamins for incorporation into feedingstuffs, parti-
cularly milk powders and milk replacer feeds. 
The biologicial and toxicological properties of these products have 
been thoroughly investigated. Polyethylene glycols with a molecular 
weight ranging from 300 - 9000 are biologically inert when administe-
red orally or applied dermally. Their oral LD 50 ranges from 40 to 
over 50 g/kg body weight for rat and from 20 to over 50 g/kg body 
weight for guinea pig. Long-term administration of polyethylene 
glycols (M.W. 1500 and 4000) at levels of 2 % in the diet of dogs and 
4 % in the diet of rats had no adverse effects. Polyethylene glycol 
6000 is not absorbed from the digestive tract and is not affected by 
the action of intestinal microorganisms. It is recovered quantitati-
vely unchanged from the faeces. For these reasons, it is also used as 
a "marker" in studies of the process of digestibility and gastro-
intestinal absorption of certain nutrient principles. 
The biological and toxicological properties of polyoxypropylene-
polyoxyethylene polymers vary with their molecular weight and the 
weight ratio between the chains of polyoxypropylene and polyoxy-
ethylene. The polymer of molecular weight 6800 - 9000, having about 
80 % by weight of polyoxyethylene chains and 20 % by weight of poly-
oxypropylene chains, has little toxicity for rats, mice, guinea pigs, 
dogs or rabbits. The oral LD 50 for these species is above 15 g/kg 
body weight. The administration of the product for six months at 
levels of 0.1 and 0.05 mg/kg body weight in the diet of dogs and for 
two years at the levels of 3 % and 5 % in the diet of rats produced 
no adverse biochemical, haematological or histopathological changes 
and dit not affect growth or rate of survival. A marked reduction of 
growth was observed in the rat only at a concentration of 7.5 % in 
the diet. Orally administered, the product is not metabolized and is 
recovered quantitatively unchanged from the faeces. 
No sensitization or irritant effects were found on repeated dermal 
application to dog, rabbit, guinea pig and man. 
2. Since orally administered polyethylene glycol 6000 and polyoxypropy-
lene-polyoxyethylene polymer are neither absorbed from the digestive 
tract nor metabolized in the organism, they are unlikely to influence 
the quality of animal products. 
3. In view of the data presented, the Committee is of the opinion that 
the use of polyethylene glycol 6000 and of polyoxypropylene-polyoxy-
ethylene polymer (M.W. 6800 - 9000), under the conditions proposed 
for the preparation of vitamin premixes intended for incorporation 
into feedingstuffs, has no harmful effects on animal or human health, 
nor will it affect the quality of animal products. 
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REPORT OF THE SCIENTIFIC COMMITTEE FOR ANIMAL NUTRITION 
ON THE USE OF ARPRINOCID 
IN FEEDINGSTUFFS FOR CHICKENS 
Opinion expressed 11 December 1980 
TERMS OF REFERENCE (March 1980) 
The scientific Committee for Animal Nutrition is requested to give an 
opinion on the following questions : 
1. Does the use of the coccidiostat arprinocid in feedingstuffs for 
chickens, under the proposed conditions of use (see Background), 
result in the presence of residues in animal products ? Could these 
residues be harmful to the consumer ? 
2. Could the use of this additive affect the development of resistance 
in bacteria ? 
3. Could the excreted products, derived from the additive, be prejudicial 
to the environment ? If so, what is the nature of the risks ? 
4. In the light of the answers to the above question, are the proposed 
conditions of use acceptable ? 
BACKGROUND 
Arprinocid was the subject of a submission for inclusion in Annex II, 
Section B, of Council Directive 70/524/EEC of 23 November 1970, concer-
ning additives in feedingstuffs (1), under the following proposed con-
ditions for use : 
Species of animal : chickens for fattening. 
Minimum and maximum content in complete feedingstuffs : 60 ppm (mg/kg). 
Other provisions : use prohibited at least two days before slaughter. 
(1) OJ No L 270, 14.12.1970, p. 1 
(3) 
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OPINION OF THE COMMITTEE 
1. Studies of the metabolism of arprinocid (9-(2-chloro-6-fluorophenyl-
methyl) 9H-purin-6-amine) in chicken, using the C-methylenelabel-
led compound, show that the compound is rapidly metabolized to the 1-
N-oxide, the hypoxanthine, the 2-chloro-6-fluorobenzylalcohol and 
the 2-chloro-6-fluorobenzoic acid. Only about 0.25 % of administered 
radioactivity is excreted as C0_, establishing the metabolic stabi­
lity of the methylene bridge. Ninety four per cent of the administered 
radioactivity appears in the mixed excreta; less than 0.1 per cent is 
found in each of the major organs and in the carcass except for 
0.18 % in the liver and 0.37 % in the intestine stripped of its 
content. 
In surgically altered chicken, permitting separate collection of 
urine and faeces, 50 % of the administered radioactivity appears in 
the urine. About one third of the urinary activity is unchanged 
arprinocid, one third is the 1-N-oxide, one eigth the benzylalcohol 
derivative and one thirtieth each the hypoxanthine and the benzoic 
acid derivative. There are considerable species differences in the 
quantitative but not the qualitative distribution of the urinary 
metabolites. Residues of arprinocid in tissues and organs appear to 
consist essentially of 50 % arprinocid, 10 % hypoxanthine and 0.6 % 
of 1-N-oxide, and the remainder is unidentified metabolites. Residues 
are found mainly in the liver and kidneys, very little appearing in 
muscle, skin and fat. 
Residues in tissues and organs of chicken, fed for various times up 
to several weeks on a ration containing 70 ppm arprinocid,were 
determined by reverse isotope dilution assays or gas chromatography 
with electron capture (sensitivity : 50 ppb, limit of detection : 20-
30 ppb). 
Three days after withdrawal only about 0.3 ppm residues were detec­
table in the liver and 0.15 ppm in the kidneys, while none could be 
detected in other tissues. Five days after withdrawal the liver 
residues ranged from 0.17 - 0.22 ppm. These liver residues consisted 
of at least two pools, one representing 85 - 90 % of the residues and 
consisting essentially of unchanged arprinocid (depletion halflife 
1.7 days). The other pool, representing various metabolites, included 
the 1-N-oxide (depletion halflife 3.5 days). The liver residues 
appeared to be associated with the macromolecular cellular consti­
tuents and were thus largely not bio-available (only 18 % ) . There 
were no bio-available residues in liver and kidneys after 5 days 
withdrawal. 
1 Λ 
C-labelled arprinocid is well absorbed in rats, 65 % of the radio­
activity appearing in the urine, 30 % in the bile and 5 % in the 
faeces.during the 72 hours after administration. When liver contai­
ning C-labelled arprinocid residues (0.2 ppm after 5 days with­
drawal) was fed to rats, most of the activity appeared in the faeces, 
the net absorption being less than 0.05 ppm. 
Arprinocid was investigated in short- and long-term toxicological 
studies in laboratory animals. The compound possesses hepatic and 
renal toxicity at high doses as well as having effects on the epi-
thelial and cardiovascular systems manifested by necrosis of ears and 
tails. It appears to be teratogenic in the rat and mouse but not in 
the rabbit. This activity is due most likely to the 1-N-oxide metabo-
lite. There was no evidence of carcinogenicity in the two rodent 
species (rat and mouse) tested nor was there any mutagenic potential 
demonstrable both in in vivo and in vitro tests. The no-adverse-
effect level in the most sensitive species (mouse) was 1 mg/kg body 
weight. Separate investigation of the 1-N-oxide metabolite revealed 
no additional toxic potential. 
The low bio-availability of the residues in the liver of chicken 
following relay toxicity tests adds a further safety factor. 
2. The absence of activity of arprinocid on various species of micro-
organisms tested in vitro (ten bacterial and two fungal strains) 
indicates that the product has no antimicrobial properties. 
3. Studies on the excretion of arprinocid in chicken showed that, under 
the proposed conditions of use, about 95 % of the amount ingested 
appears in the excreta within 24 hours after administration. The 
excreted material is composed of 50 % arprinocid, 4 % 1-N-oxide, 
about 16 % polar water-soluble metabolites and 7 % bound to faecal 
solids. 
Aqueous solutions of arprinocid are sensitive to photodegradation, 
some 70 % being photolysed in 7 days. Tests performed under aerobic 
and anaerobic conditions showed a slow degradation of arprinocid in 
undiluted chicken excreta. When excreta were incorporated into dif-
ferent soils, the residues were retained strongly in the soil and 
little leaching by water occured. The halflife of residues in soil 
was about 56 days, being slowly degraded to C0_ and organic volatiles 
by aerobic processes. 
Arprinocid had low toxicity for algae and fish but was moderately 
toxic for daphnia. No phytotoxicity was observed in tests carried out 
in millet, rice, beans, cabbage, cucumber, tomato, carrot and corn 
crops. These observations indicate that contamination of the environ-
ment is unlikely. 
4. The Committee is of the opinion, in the light of the available facts, 
that the use of arprinocid in feedingstuffs for chickens, at a level 
of 60 ppm (mg/kg), is acceptable provided a withdrawal period of at 
least 5 days before slaughter is imposed. 
REFERENCES 
Dossiers Merck and Co Inc. 
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REPORT OF THE SCIENTIFIC COMMITTEE FOR ANIMAL NUTRITION 
ON THE USE OF INACTIVATED CULTURES 
OF SELECTED ENTEROPATHOGENIC STRAINS OF E. COLI 
IN FEEDINGSTUFFS FOR PIGLETS 
Opinion expressed 11 March 1981 
TERMS OF REFERENCE (June 1980) 
The Scientific Committee for Animal Nutrition is requested to give an 
opinion on the following questions : 
1. For what reasons can preparations of inactivated cultures of selected 
enteropathogenic strains of E. coli not be considered as vaccines ? 
If they are not vaccines, should feedingstuffs supplemented with 
these preparations not be considered as medicated feedingstuffs 
particularly because of their immunological effects ? 
(x) 
2. What are the effects of Intagen on piglets and sows when this 
preparation is incorporated in the ration according to the proposed 
conditions of use (see Background) ? Are these effects significant in 
healthy farm livestock with no colibacillary infection symptoms ? Has 
the administration of Intagen in feedingstuffs for pregnant sows a 
significant influence on the effects observed in piglets ? 
3. Are Intagen preparations other than the one mentioned in the dossier 
submitted in support of the request for its admission as an additive 
in feedingstuffs for piglets and sows, used for animal production ? 
Is Intagen used for human or veterinary therapeutic purposes ? 
4. Could the use of Intagen under the proposed conditions (see Back-
ground) favour the selection of intestinal bacteria resistant to 
therapeutic agents used for pigs ? 
5. Is this use without risk for : 
- the consumer , 
- the people involved in livestock rearing ? 
- the environment ? 
6. If Intagen satisfies the requirements for admission as an additive in 
feedingstuffs, what should be the administration period of the supple-
mented feed for piglets and sows and the maximum levels of the active 
principles in complete feedingstuffs ? 
(x) Registered trade name 
19 
BACKGROUND 
Intagen was the subject of a submission in Annex II, section F, of 
Council Directive 70/524/EEC, of 23 November 1970, concerning additives 
in feedingstuffs (1), under the following conditions of use : 
Species of animal : piglets up to 10 weeks, pregnant sows. 
Dose in complete feedingstuffs5: 0.15 % minimum of a preparation con­
taining from 5 χ 10 to 2 χ 10 hemagglutination inhibition units (HIU) 
per kg. 
OPINION OF THE COMMITTEE 
1. Intagen is a heat-treated, formalinised bacterial preparation from 
seven specific serotypes of E. coli, all known porcine enteropatho-
gens; the heat treatment not only inactivates the bacteria, it also 
liberates the polysaccharide antigens from the cell walls. The 
product is incorporated in a mixture of whey powder, wheat flour and 
citric acid and the final product termed Intagen premix is a-creamy 
white, free-flowing powder containing from 5 χ 10 to 2 χ 10 HIU/kg. 
Intagen, incorporated in the feed acts by stimulating the cells on 
the surface of the intestinal villi to produce specific IgA anti­
bodies to the seven serotypes of E. coli used in its preparation. 
It should be noted that the intestine is equipped with a specialised 
surface immunity to counter the harmful effects of pathogenic bac­
teria. This antibody system is different from other immune systems in 
the body in that it can only be activated by a direct application of 
the antigen onto the absorptive cells covering the villi. Injectable 
vaccines are very inefficient in stimulating the surface immune 
system. A feature of the secretory immune system is that it is not 
long lasting unlike normal blood borne immunity in which a single 
course of vaccination will provide protection for a considerable 
period of time. Antibody production (IgA) by the secretory system 
persists only for as long as the stimulating antigens are present. 
Intagen does not have a long-term effect and must be continually 
administered. It acts by increasing resistance against specific 
pathogenic E. coli infection and thus feed containing it cannot be 
considered as medicated for therapeutic use. 
2. Numerous trials with healthy young piglets have shown that incorpo­
ration of Intagen in the feed for an extended period of time improved 
weight-gain and feed conversion efficiency. In herds where E. coli 
infection was severe in the control piglets, its presence in the feed 
greatly reduced piglet mortality, increased the number of piglets 
weaned/litter and reduced more than half the requirement for other 
medi cation. 
(1) 0J No L 270, 14.12.1970, p. 1 
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In sows, the continuous ingestion of Intagen with the feed from 
6 weeks prefarrowing has a limited effect in increasing the immuno­
logical activity of the colostrum. 
3. To achieve maximum potency of antigen activity in the colostrum of 
sows it is recommended that at 3 weeks before farrowing the sows, 
already receiving Intagen premix in their feed (see 2. above) are 
given a single parenteral infection of 'Intagen Injectable'. This 
product is a sterile preparation of the E. coli polysaccharides 
prepared from the heat-treated formalinised preparation referred to 
in 1. above. Its mode of action consists in stimulating blood borne 
immunity; the effect is long lasting and entirely different from that 
of the Intagen premix included in the feed. There is a synergistic 
effect between the oral and parenteral route in stimulating antigenic 
potency of the colostrum. 
Neither product is used for human or veterinary therapeutic purposes. 
4. There is no evidence that Intagen used under the conditions proposed 
(see 6. below) favours the selection of intestinal bacteria resistant 
to therapeutic agents. Studies have shown that during Intagen admi­
nistration the numbers of coliform and sulphite-reducing bacteria 
inhabiting the intestine are reduced while the numbers of enterococci 
and Lactobacilli are increased. There is no evidence of increased 
numbers of any harmful bacteria present in the intestine after treat­
ment has been stopped. Indeed, since the product is only specific 
against certain serotypes of E. coli, the intestinal flora is normal 
after treatment ceases. There is no adaptation of the strains of 
E. coli used in the preparation of Intagen to its continued use and 
the question of resistance developing in other E. coli strains pre­
sent within the intestine does not exist by virtue of the known mode 
of action of the product. 
5. The nature of Intagen excludes any possibility of harmful residues in 
animal products resulting from the feeding of it to piglets or sows. 
There is no risk for the consumer. Tests with guinea pigs show the 
absence of danger due to inhalation; the effects are much Less than 
those caused by an egg albumin aerosol. There is no adverse effect on 
the environment resulting from its use, indeed the opposite may be 
true since its use reduces the environmental burden of toxic E. coli 
species. 
6. The Committee considers that the conditions of use of the product 
should be the following : 
a) in the feed of young piglets up to 77 days of age or when the 
animals reach 25 kg liveweight; maximum level in complete fee~5 
dingstuffs : 1 % of a preparation containing 5 χ 10 to 2 χ 10 
HIU/kg. 
b) in the feed of sows for the period of 6 weeks prefarrowing to 
3 weeks postfarrowing; maximum level in complete feedingstuffs : 
0.15 % of a preparation containing 5 χ 10 to 2 χ 10 HIU/kg. 
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GUIDELINES FOR THE ASSESSMENT OF CERTAIN PRODUCTS 
TO BE USED AS A SOURCE OF PROTEINS 
IN ANIMAL NUTRITION 
GENERAL ASPECTS 
This document is intended as a guide for establishing dossiers on non-
traditional products obtained from culturing microorganisms and proposed 
as a new source of proteins in animal nutrition. These dossiers should 
enable an assessment of such products based on the present state of 
knowledge and should ensure their compliance with the fundamental prin-
ciples laid down for permitting their use, which are the subject of the 
provisions of Article 6(2) of the proposal for a Council Di rective^of 
20 July 1977, concerning certain products used in animal nutrition 
All the studies outlined in this document may be required and, if neces-
sary, additional information may be requested. As a general rule, all 
the information necessary to establish the identity of the microorganism 
and the composition of the culture medium, and also the manufacturing 
process, characteristics, presentation, conditions of use, methods of 
determination and nutritional properties of the product must be provi-
ded. The same applies to the information necessary to assess the tole-
rance of the product by the target species and the risks for man and the 
environment, which could result directly or indirectly from the use of 
the product. The toxicological studies required for this purpose will 
depend on the nature of the product, the animal species concerned and 
the metabolism of the product in laboratory animals. 
The documentation to be provided should include detailed reports, pre-
sented in the order and with the numbering proposed in these guidelines 
and should be accompanied by a summary. The omission of any proposed 
studies should be justified. The publications quoted as references 
should be attached. 
OBSERVATIONS 
The term "product", as used in these guidelines, refers to any non-
traditional proteinaceous product obtained from culturing microorganisms 
in the state in which it will be presented as feedingstuff or component 
of a feedingstuff. 
Any modification in the manufacturing process or in the conditions of 
use of a product will require notification and, if necessary, additional 
documentation for a new assessment. 
The guidelines will be updated as new scientific knowledge develops. 
(1) OJ No C 197, 18.08.1977, p. 3 
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PRESENTATION OF STUDIES 
I. Microorganism, culture medium and manufacturing process, charac-
teristics of product, presentation and conditions of use, methods 
of determination. 
II. Studies on the nutritional properties of the product. 
III. Studies on the biological consequences of the use of the product in 
animal nutrition. 
IV. Other relevant studies. 
SECTION I : MICROORGANISM, CULTURE MEDIUM AND MANUFACTURING PROCESS, 
CHARACTERISTICS OF PRODUCT, PRESENTATION AND CONDITIONS 
OF USE, METHODS OF DETERMINATION 
1. MICROORGANISM 
1.1. Classification, morphology, biological properties, any genetic 
manipulation. 
1.2. Innocuity, possible survival outside the fermenter and environ-
mental consequences. 
1.3. Constancy and purity of strains cultivated. Methods used to check 
these criteria. 
2. CULTURE MEDIUM AND MANUFACTURING PROCESS 
2.1. Composition of substrate, added substances, etc. 
2.2. Manufacturing and purification processes. Methods used to check 
the constancy of composition of the culture product and the 
detection of any chemical and biological contamination during 
production. 
2.3. Technical processes of preparation for use. 
3. CHARACTERISTICS OF PRODUCT 
3.1. Physical and physico-chemical properties : macro- and micro-
morphology, particle size, density, specific weight, hygrosco-
picity, solubility, solution characteristics (pH, rheological 
characteristics), electrostatic properties, etc. 
3.2. Chemical composition : 
3.2.1. Content of moisture, crude protein, crude fat, crude fibre, 
ash, nitrogen-free extract. Limits of variation. 
3.2.2. Content of total, ammonium, amide, nitrate and nitrite nitrogen, 
true protein. Qualitative and quantitative composition of total 
and free amino acids, nucleic acids (purine and pyrimidine bases). 
(4) 
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3.2.3. Qualitative and quantitative composition of total lipids : fatty 
acids, non-saponi fiable matter, lipid soluble pigments, etc. 
3.2.4. Qualitative and quantitative composition of carbohydrates and 
related substances. 
3.2.5. Qualitative and quantitative composition of inorganic components. 
3.2.6. Qualitative and quantitative composition of vitamins. 
3.2.7. Qualitative and quantitative compositon of the other consti-
tuents : additives, residues of substrate and solvents, conta-
minants (in particular, polycyclic aromatic hydrocarbons, nitro-
samines), etc. 
3.3. Contamination by microorganisms during the manufacturing process. 
3.4. Behaviour and stability of the product, as such and when mixed 
with feedingstuffs in current use, during storage. 
4. PRESENTATION AND CONDITIONS OF USE 
4.1. Proposed names for marketing the product. 
4.2. Proposed formulations for marketing the product. 
4.3. Intended use of the product in animal nutrition. Proposed con-
centrations in complete and complementary feedingstuffs for the 
animal species concerned. 
5. METHODS OF DETERMINATION 
Qualitative and quantitative methods for determination of the 
product in complete and complementary feedingstuffs. 
N.B. : Description of these methods should be accompanied by in-
formation as to specificity, sensitivity, limits of de-
tection, margin of error, possible interferences by other 
substances. Samples of the product in its various proposed 
presentations should be available. 
SECTION II : STUDIES ON THE NUTRITIONAL PROPERTIES OF THE PRODUCT 
1. ASSESSMENT OF PROTEIN VALUE 
1.1. Chemical and/or microbiological studies. 
1.2. Studies on laboratory animals (preferably rats) : digestibility, 
protein efficiency ratio (PER), biological value of the product 
compared with reference proteins. 
2. STUDIES ON TARGET SPECIES 
The following studies should be performed on each target species 
in comparison with a control group receiving, under the same con-
ditions of nutritional balance, a diet in current use containing 
equivalent amounts of protein nitrogen. 
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2.1. Protein and energy supplementation value of the product in the 
rations under the proposed conditions of use at various physio-
logical stages of the animals (growing period, pregnancy, laying, 
etc.). 
2.2. Influence of the product under the proposed conditions of use on 
growth rate, feed conversion rate, morbidity, mortality, etc. 
2.3. Optimum levels of incorporation of the product in the rations. 
2.4. Effect of the product under the proposed conditions of use on the 
composition and on nutritive, technological and organoleptic 
quality of meat, offal, eggs and milk. 
3. EXPERIMENTAL CONDITIONS IN THE STUDIES ON TARGET SPECIES 
Give a detailed description of the tests performed and provide 
the following data : 
3.1. Species, breed, age and sex of the animals, identification 
procedure. 
3.2. Number of test and control groups; number of animals in each 
group (the number should be large enough for statistical analysis 
using suitable statistical parameters). 
3.3. Levels of incorporation of the product, qualtitative and quan-
titative composition of the ration and its analysis. 
3.4. Location of each experiment, physiological state and animal 
health conditions, rearing conditions (these should reflect those 
used in practice in the Community). 
3.5. Exact duration of testing and date of the analyses performed. 
3.6. Adverse effects which occured during the experiment and time of 
their appearance. 
SECTION III : STUDIES CONCERNING THE BIOLOGICAL CONSEQUENCES OF THE 
USE OF THE PRODUCT IN ANIMAL NUTRITION 
The studies outlined in this section are intended to permit assessment 
of the safety in use of the product in the target species, and of the 
risks for man and the environment which could result directly or in-
directly from this use. The toxicological studies required for this 
purpose will depend on the nature of the product, the animal species 
concerned and the metabolism of the product in laboratory animals. 
1. STUDIES ON TARGET SPECIES 
The following studies should be performed on each target species 
in comparison with a control group receiving, under the same con-
ditions of nutritional balance, a diet in current use containing 
equivalent amounts of protein nitrogen. 
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1.1. Maximum incorporation rates of the product in the ration without 
producing any adverse effect. 
1.2. Effects of ingestion of the product under the proposed conditions 
of use on microorganisms of the flora of the alimentary tract and 
on colonization of pathogens in the alimentary tract. 
1.3. Investigation under the proposed conditions of use of possible 
residues of the product (substrate, culture medium, solvents, 
contaminants) in animal products (meat, milk, eggs, etc.). 
1.4. Investigation under the proposed conditions of use of possible 
residues of the product (substrate, culture medium, solvents, 
contaminants) in excreta. 
2. STUDIES ON LABORATORY ANIMALS 
2.1. Metabolism 
Fate of the product in the animal : absorption, elimination, etc. 
2.2. Mutageni city 
Investigations of potential mutagenicity due to contaminants (in 
particular mycotoxins) or residues of the product (substrate, 
culture, medium, solvents), including in vitro screening tests 
using metabolic activation systems. 
2.3. Toxicological studies 
The following studies should be performed in comparison with 
control groups receiving, under the same conditions of nutriti-
onal balance, a diet in current use containing equivalent amounts 
of protein nitrogen. Toxic effects should be investigated to elu-
cidate their cause and mechanisms and to ascertain that they do 
not result from nutritional imbalance or from an overdosage of 
the product in the diet. 
2.3.1. Subchronic toxicity (at least 90 days) 
In general, these studies should be carried out on two animal 
species, one of which being a rodent. The product should be 
administered in the daily ration in at least two levels of in-
corporation. If possible, these should be chosen so as to de-
termine a no-effect level and a level showing some adverse effect. 
The experimental groups should contain an adequate number of 
animals of each sex. A control group should always be included. 
All relevant biological data should be recorded at appropriate 
intervals, particularly data on growth rate, feed consumption, 
haematology, urine analysis, biochemical parameters, mortality, 
organ weights, gross pathology and histopathology of major organs 
and tissues. The results should be presented in detail and, as 
far as possible, should include statistical assessment. 
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2.3.2. Chronic Toxicity 
In general, chronic toxicity studies should be carried out on two 
animal species, one of which being a rodent. The product should 
be administered in the daily ration in at least two levels of 
incorporation. Experiments should extend for a minimum of two 
years in the rat or 80 weeks in mice. The experimental groups 
should contain an adequate number of animals of each sex. A 
control group should always be included. The experiment, if 
continued beyond the minimum period, should be terminated when 
survival in any but the group with the highest level of incorpo-
ration has fallen to 20 %. 
The biological examinations mentioned under item 2.3.1. should be 
carried out preferably on a small satellite group of animals at 
appropriate intervals throughout the experiment and on the sur-
viving animals at the end of the experiment. For assessing 
carcinogenicity, particular attention should be paid to the time 
of appearance, the histological types of any observed tumours and 
their incidence. Any effect on the incidence of tumours and/or 
the incidence or progress of diseases should be assessed by 
reference to control groups, as indicated in paragraph 2.3. The 
result should be presented in detail and, as far as possible, 
should include statistical assessment. 
2.4. Other studies 
Reproduction studies should extend over at least two filial 
generations and may be combined with embryotoxicity including 
teratogenicity studies. Particular attention should be paid to 
fertility, fecundity and observation on post-natal development of 
litters. 
2.5. Experimental conditions in the studies on laboratory animals 
Give detailed description of the tests performed and provide the 
following data : 
2.5.1. Species, breed, strain and sex of animals. 
2.5.2. Number of test and control groups, number of animals in each 
group (the number should be large enough for statistical analysis 
using suitable statistical parameters). 
2.5.3. Levels of incorporation of the product, qualitative and quanti-
tative composition of the ration and its analysis. 
2.5.4. General rearing conditions throughout the period of testing. 
2.5.5. Exact duration of testing and date of examinations performed. 
2.5.6. Rate and timing of deaths for the various test groups. 
2.5.7. Pathological incidents which occurred during the experiment and 
time of their appearance. 
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STUDIES CONCERNING THE ENVIRONMENT 
Depending on the nature of possible residues of the product 
(substrate, culture medium, solvents, contaminants) in excreta of 
target species, data on the fate of these residues in manure, 
soil and water and also their effects on soil biology, plant 
growth and aquatic life may be required. 
SECTION IV : OTHER RELEVANT STUDIES 
Depending on the nature and the conditions of use of the product, data 
on allergic effects, on irritation of the skin and mucous membranes of 
the eye, respiratory or digestive tract may be required to assess pos-
sible risks in handling the product and to prevent them. 
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